Medico Remedies Ltd Announces Commencement of Work for New Factory with 25 Crore Revenue Expectation

Medico Remedies Ltd, a WHO-GMP, ISO 9001-2015 & Govt. Recognised Star Export House, has announced the commencement of work for a new factory. The new factory will be used for manufacturing B lactum tablets, capsules, dry syrup, and injections, including amoxycillin + clauvulinic acid formulations. The factory will have a capacity of 25 million tablets, 45 million capsules, 10 million dry syrups, and 10 million injectables. The state-of-the-art facility will be made as per PIC/S guidelines and is expected to add about 25 crores revenue after receiving all approvals. The existing capacity of the current plant is 300 million tablets, 150 million capsules, and 20 million dry syrup. The existing capacity utilization is 70%. The investment required for the new factory is Rs. 30 Crore, which will be financed through internal accruals and debt. The new factory is expected to start production within 2 years.